Gelesis 400

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instanceOf medical product
gptkbp:applicationStatus approved
gptkbp:availability available by prescription
available over the counter in some regions
gptkbp:clinicalTrials Phase 3
study on efficacy
study on safety
Gelesis_400_adherence_study
Gelesis_400_clinical_trial_1
Gelesis_400_clinical_trial_2
Gelesis_400_dietary_intervention_study
Gelesis_400_economic_impact_study
Gelesis_400_impact_on_comorbidities_study
Gelesis_400_lifestyle_intervention_study
Gelesis_400_long-term_safety_study
Gelesis_400_long-term_study
Gelesis_400_metabolic_study
Gelesis_400_patient-reported_outcomes_study
Gelesis_400_psychological_impact_study
Gelesis_400_quality_of_life_study
Gelesis_400_safety_study
Gelesis_400_vs_placebo_study
Gelesis_400_weight_loss_efficacy_study
Gelesis_400_effectiveness_in_diverse_populations_study
gptkbp:developedBy gptkb:Gelesis_Inc.
gptkbp:dosageForm capsule
gptkbp:formulation hydrogel
https://www.w3.org/2000/01/rdf-schema#label Gelesis 400
gptkbp:ingredients water
gelatin
citric acid
titanium dioxide
glycerin
potassium citrate
magnesium stearate
sodium alginate
gptkbp:issuedBy oral capsule
gptkbp:manufacturer gptkb:Gelesis_Inc.
gptkbp:market 2020
gptkbp:marketedAs brand_name_Gelesis_400
gptkbp:patentStatus patented
gptkbp:regulatoryCompliance received_FDA_approval
gptkbp:researchInterest clinical trial results
efficacy studies
published in medical journals
patient satisfaction studies
long-term effects studies
dietary impact studies
metabolic effects studies
safety profile studies
weight loss studies
comparative studies with other weight loss products
gptkbp:route oral
gptkbp:sideEffect nausea
abdominal pain
diarrhea
gptkbp:suitableFor 2 capsules before meals
gptkbp:targetMarket gptkb:Canada
gptkb:European_Union
gptkb:United_States
gptkbp:targets overweight and obese adults
gptkbp:triggerType expands in the stomach
gptkbp:usedFor weight management